Mendaera
Private Company
Total funding raised: $29M
Overview
Mendaera is a private, pre-revenue medical device innovator based in Redwood City, California, focused on robotic-assisted procedural guidance. Its core product, the Focalist System, has received FDA clearance and represents a novel category of handheld robotics integrated with ultrasound imaging to improve needle placement accuracy. The company is backed by notable venture capital firms and is targeting a 2026 commercial launch, with initial clinical use demonstrated in advanced kidney stone surgery. Mendaera's mission is to democratize complex procedural skills, enabling safer and more consistent outcomes across healthcare settings.
Technology Platform
Handheld robotic system integrated with real-time ultrasound imaging for precision guidance in needle-based procedures.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Mendaera operates in the emerging segment of compact, handheld robotic guidance. It faces potential competition from large-cap robotic surgery companies (e.g., Intuitive Surgical) if they develop similar access platforms, as well as from traditional manual ultrasound and alternative electromagnetic or optical navigation systems. Its key differentiation is the integrated handheld form factor designed to augment, not replace, the clinician's natural technique.